Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 701-325-7 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Eye irritation
Administrative data
- Endpoint:
- eye irritation: in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- April 2004
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Study conducted in compliance with agreed protocols, with no or minor deviations from standard test guidelines and/or minor methodological deficiencies, which do not affect the quality of relevant results.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 004
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 405 (Acute Eye Irritation / Corrosion)
- Deviations:
- no
- GLP compliance:
- yes
Test material
- Reference substance name:
- Iron (II) chloride
- Molecular formula:
- FeCl2
- IUPAC Name:
- Iron (II) chloride
- Details on test material:
- Substance name: Iron dichloride (¿)(CAS No.7758-94-3)
Lot No.: 23828CB
Acceptance date: February 11, 2004
Appearance: Pale brown powder
Purity: 98%
Storage conditions: Brown bottle, dry place, sealed
Constituent 1
Test animals / tissue source
- Species:
- rabbit
- Strain:
- New Zealand White
- Details on test animals or tissues and environmental conditions:
- TEST ANIMALS
- Source: : Samtaco Bio Korea, 77-1 Seorang-dong, Osan-si, Gyeonggido, Korea
- Age at study initiation: 4 to 5 months old
- Weight at study initiation: 2200 ~2400g
- Housing: Stored individually in cages
- Diet (e.g. ad libitum): The animals were fed rabbit feeds (Purina Korea located in 85-1 Jangdang-dong, Pyeongtaek, Gyeonggido)
- Water (e.g. ad libitum): The water was sterilized with UV.
- Acclimation period: Not stated
ENVIRONMENTAL CONDITIONS
- Temperature (°C): temperature was set at 20±2¿
- Humidity (%): relative humidity at 50±10 %
- Air changes (per hr): 10-15
- Photoperiod (hrs dark / hrs light): lighting time at 12 hours (8 a.m. to 8 p.m.) and illumination at 200 to 300 Lux.
IN-LIFE DATES: From: Day 0 To: Day 14
Test system
- Vehicle:
- unchanged (no vehicle)
- Controls:
- no
- Amount / concentration applied:
- TEST MATERIAL
- Amount(s) applied (volume or weight with unit): The powder was finely ground and weighed on the day of testing. 0.1 g of the powder of iron dichloride (¿)(CAS No.7758-94-3) was applied to the conjunctiva of the eye.
According to MSDS, LD 50 was 450 mg/kg in the case of oral administration and 59 mg/kg in the case of intraperitoneal injection. Therefore, as irritations by the test substance were anticipated, an initial test was conducted on one rabbit before the confirmative test was conducted.
VEHICLE
Not applicable no vehicle used - Duration of treatment / exposure:
- The test substance was applied once.
- Observation period (in vivo):
- Temperature and humidity were automatically measured in the animal chamber every hour during the test period.
Clinical signs, poisoning and mortality were checked till 72 hours from the application. Continued eye irritation was observed, so the observation lasted till Day 21.
The presence of irritation on the cornea, iris and conjunctiva was checked with the both-eye real microscope (Leica S6E, Germany) at 1 hour, 24 hours, 48 hours, and 72 hours after the application and was observed up to 21 days. - Number of animals or in vitro replicates:
- 3 females
- Details on study design:
- SCORING SYSTEM:
Evaluation of eye irritation and irritation determination (KOTRIC-EIT-001)
The determination of irritation was based on the table 1 ‘Grade of eye lesion’. Eye lesion scores were calculated at each observation time depending on the degree of eye lesion. The scores must not be used as criteria. Each score can be meaningful when it was suggested with all the observation items and descriptions. The eye irritation scores were calculated as with the severity and characteristics of the lesion, reversibility or reversibility loss.
Grade of eye lesion
(1) Cornea
(A) Diffuse area of opacity: degree of opacity (Observe the most opaque area)
¿ No ulcer or opacity
¿ Opacity is scattered or distributed (different from a little spoiled normal transparency), but the iris is clearly observed.
¿ Semi-opaque areas are easily observed, but the fineness of the iris is a bit unclear.
¿ Pearly color, and the iris is not finely observed. The size of the pupil is barely observed.
¿ The cornea is opaque and turbid, so the iris cannot be distinguished.
(2) Iris
¿ Normal
¿ Forms deep wrinkles. Hyperemia, Edema, Single or complicated hyperemia of moderate severity around the cornea, delayed response of the iris to light (Delayed response is positive.)
¿ No response to light, bleeding, broad destruction (some of the symptoms mentioned above or all)
(3) Conjunctiva
A. Redness (eyelid, conjunctiva, cornea, iris)
¿ Normal blood vessel
¿ Clear hyperemia in a few blood vessels
¿ Wide-spread scarlet color, blood vessels not easily distinguished
¿ Wide-spread crimson red
B. Conjunctival edema (eyelid and/or nictitating membrane)
¿ Not swollen
¿ A little more edema than normal (Including nictitating membrane)
¿ Outstanding edema with partial eversion of the eyelid
¿ Edema of eyelid as severe as eyes are half closed
¿ Edema of eyelid as severe as eyes are closed more than half
TOOL USED TO ASSESS SCORE:
The tool used to assess the score was the both-eye real microscope (Leica S6E, Germany)
Results and discussion
In vivo
Resultsopen allclose all
- Irritation parameter:
- cornea opacity score
- Basis:
- animal #1
- Time point:
- 24/48/72 h
- Score:
- 2.33
- Max. score:
- 4
- Reversibility:
- not fully reversible within: 21 days
- Irritation parameter:
- cornea opacity score
- Basis:
- animal #2
- Time point:
- 24/48/72 h
- Score:
- 3
- Max. score:
- 4
- Reversibility:
- not fully reversible within: 21 days
- Irritation parameter:
- cornea opacity score
- Basis:
- animal #3
- Time point:
- 24/48/72 h
- Score:
- 3.3
- Max. score:
- 4
- Reversibility:
- not fully reversible within: 21 days
- Irritation parameter:
- iris score
- Basis:
- animal #1
- Time point:
- 24/48/72 h
- Score:
- 1.33
- Max. score:
- 2
- Reversibility:
- not fully reversible within: 21 days
- Irritation parameter:
- iris score
- Basis:
- animal #2
- Time point:
- 24/48/72 h
- Score:
- 1.66
- Max. score:
- 2
- Reversibility:
- not fully reversible within: 21 days
- Irritation parameter:
- iris score
- Basis:
- animal #3
- Time point:
- 24/48/72 h
- Score:
- 1.66
- Max. score:
- 2
- Reversibility:
- not fully reversible within: 21 days
- Irritation parameter:
- conjunctivae score
- Basis:
- animal #1
- Time point:
- 24/48/72 h
- Score:
- 2.33
- Max. score:
- 3
- Reversibility:
- not fully reversible within: 21 days
- Irritation parameter:
- conjunctivae score
- Basis:
- animal #2
- Time point:
- 24/48/72 h
- Score:
- 2.33
- Max. score:
- 3
- Reversibility:
- not fully reversible within: 21 days
- Irritation parameter:
- conjunctivae score
- Basis:
- animal #3
- Time point:
- 24/48/72 h
- Score:
- 2.66
- Max. score:
- 3
- Reversibility:
- not fully reversible within: 21 days
- Irritation parameter:
- chemosis score
- Basis:
- animal #1
- Time point:
- 24/48/72 h
- Score:
- 2.66
- Max. score:
- 4
- Reversibility:
- not fully reversible within: 21 days
- Irritation parameter:
- chemosis score
- Basis:
- animal #2
- Time point:
- 24/48/72 h
- Score:
- 3.66
- Max. score:
- 4
- Reversibility:
- not fully reversible within: 21 days
- Irritation parameter:
- chemosis score
- Basis:
- animal #3
- Time point:
- 24/48/72 h
- Score:
- 4
- Max. score:
- 4
- Reversibility:
- not fully reversible within: 21 days
- Irritant / corrosive response data:
- In the initial test, irritation was observed in the cornea, iris and conjunctiva in the applied region at 1 hour. So two more animals were tested in the confirmative test and the applied regions were observed. As a result of observation at 1 hour, and Days 1, 2, 3, 7, 14, and 21, the opacity was observed in the cornea of all the animals at all observation times. At Day 21, one rabbit was observed to be in the first stage recovery and the opacity did not disappear in the rest two rabbits. All the animals did not show the response of iris to light at Days 2-3 and hyperemia was observed in all of them. Severe redness (Grade 1 ~ 3), severe excretion and yellow pigmentation were observed in the conjunctiva of all the subjects. Severe edema (Grade 2 ~4) was observed in the conjunctiva and nictitating membrane of all the animals. The redness and edema began to relieve in Animal No. 1 at Day 7, in Animal No. 2 at Day 4 and Animal No. 3 at Day 14. With the relieved edema, the deformation of upper and lower eyelids was observed.
- Other effects:
- Clinical signs and mortality:
All the animals showed reduced mobility and two animals were observed to rub the eye with front paws. No mortality was observed. Head tilting was observed in one rabbit in the initial test and one rabbit in the confirmative test.
Body weight change:
All the animals weighed more at Day 21 after the application than at Day 0.
Any other information on results incl. tables
After 0.1 g of the test substance was applied in the conjunctiva to study the eye irritation of iron dichloride(¿)(CAS No.7758-94-3)in three New Zealand White female rabbits,mortality, clinical signs and body weight changes were observed for 21 days and the eye irritation was evaluated at 1 hour, and Days 1, 2, 3, 7, 14 and 21. During the test period, all the animals showed reduced mobility and two rabbits were observed to rub their eyes with front paws. This was the reaction of rabbits sensitive to the eye irritation because the substance irritates the mucosa of the eye. No mortality was observed during the test period. Head tilting was observed in the rabbit in the initial test and one rabbit in the confirmative test. It seemed to be caused by the substance that melted in tear and flowed into the nasal cavity through the lacrimal gland. The histopathological examination found that lymphocyte nodule was formed in the submucosa of the paranasal sinus and the test substance solution affected the nasal cavity tissue through the lacrimal gland. All the animals were observed to weigh more at Day 21 than Day 0, which indicated the test substance did affect topical irritation but not the whole body.
As a result of observing the applied region at 1 hour, and Days 1, 2, 3, 7, 14, and 21, an opaque area was observed throughout the cornea of all the animals at each time. One rabbit showed stage one recovery at Day 21 and the opacity did not disappear in the rest two rabbits. All the animals showed no response of the iris to light at Days 2 ~ 3 and hyperemia was observed. Severe redness (Grade 1-3), severe excretion and yellow pigmentation were observed in the conjunctiva of all the subjects. Severe edema (Grade 2-4) was found in the conjunctiva and nictitating membrane of all the animals. The redness and edema began to relieve in Animal No. 1 at Day 7, Animal No. 2 at Day 4 and Animal No. 3 at Day 14. However, with the relieved edema, the deformation of upper and lower eyelids was observed, which indicated that the test substance caused severe purulent and inflammatory lesion because hemosiderosis and severe lymphocyte infiltration were found in the dermis in the deformed eyelids. High scores appeared even in the determination based on the Grading of eye lesion.
As a result of the histopathological examination on eyeball, conjunctiva and lesion of eyelid, granulomatous inflammation was observed in the conjunctiva, so necrosis, deformed collagen fiber and mineralization were found in the giant cell and the central part. As purulent keratitis made of neutrophils was observed in the stroma of the cornea, the test substance seemed to cause deformation in the cornea and conjunctiva. Given the fact that the iris had no histopathological lesion, the symptom in the iris was thought to disappear within 21 days. Corneal perforation, severe corneal ulcer including staphyloma, hyphema, conjunctival ulcer, and necrosis or subcutaneous tissue of the conjunctiva and nictitating membrane were not observed. The opacity of 4 scores lasted 48 hours in the cornea, but one animal was observed to be in the stage one recovery and the keratitis was diagnosed as corneal lesion which could be recovered. The response to light did not show up for 72 hours, but the histopathological examination found no abnormality in the iris. So, it was regarded as not irreversible lesion.
As a result of medicating iron dichloride to New Zealand White rabbits, the test substance was regarded as corrosive material because the lesion was not completely recovered for 21 days after the application.
Applicant's summary and conclusion
- Interpretation of results:
- Category 1 (irreversible effects on the eye)
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The substance has been classified as R41 - Risk of serious damage to the eye according to the Dangersous Substances Directive (DSD). The substance has also been classified as category 1 (cause serious damage to the eye) according to the CLP regulations.
- Executive summary:
To study eye irritation of iron dichloride (CAS No.7758-94-3) in three New Zealand White female rabbits, the subjects were dosed with the test substance. At 1 hour, and at Days 1, 2, 3, 7, 14, and 21, eye response and irritation in the cornea, iris and conjunctiva were evaluated and clinical signs were observed and body weight was measured.
The test results are as follows.
a. There was no mortality caused by the test substance during the test period.
b. Observing clinical signs, all the animals showed reduced mobility and two animals were observed to rub their eyes with frontal paws.
c. All the animals were observed to have a heavier body weight at Day 21 (after application) than at Day 0 (before application).
d. As a result of observing the applied region for local irritation at 1 hour, and Days 1, 2, 3, 7, 14, and 21, all the animals showed diffuse areas of opacity in the cornea at each observation time. An abnormality was found in the iris of all the animals, but histopathological signs were not observed. Severe redness, edema and excretion were observed in the conjunctiva of all the animals. Yellow pigmentation and exterior deformation were observed in the eyelid.
e. Hemosiderosis and lymphocyte infiltration in the submucosa of the conjunctiva were observed in the histopathological diagnosis. Granulomtous inflammation was found in the conjunctiva and purulent keratitis was observed in the corneal stroma.
Hemosiderosis and severe lymphocyte infiltration were found in the dermis of the eyelid of one animal.
In conclusion, iron dichloride (CAS No. 7758-94-3) was evaluated as a corrosive substance that caused purulent inflammation in the conjunctiva and eyelid and granulomatous inflammation and purulent keratitis in the cornea, when applied to the eye of New Zealand White rabbits. Due to this the substance has been classified as R41 - Risk of serious damage to the eye according to the Dangersous Substances Directive (DSD). The substance has also been classified as category 1 ( can cause serious damage to the eye) according to the CLP regulations EC No 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.